Loading...
XLON
AVG
Market cap186mUSD
Jul 25, Last price  
420.00GBP
1D
0.00%
1Q
23.53%
Jan 2017
117.62%
IPO
478.61%
Name

Avingtrans PLC

Chart & Performance

D1W1MN
No data to show
P/E
3,795.13
P/S
101.73
EPS
0.11
Div Yield, %
1.12%
Shrs. gr., 5y
1.11%
Rev. gr., 5y
5.60%
Revenues
137m
+17.33%
24,329,00032,490,00040,026,00041,247,00037,559,00028,578,00036,260,00043,992,00045,280,00060,265,00022,557,00021,177,00022,714,00078,864,000104,044,00091,961,00098,516,00099,075,000116,437,000136,615,000
Net income
4m
-29.50%
1,301,0001,940,000159,0001,145,0001,128,000607,0001,261,000935,0001,300,0002,914,000-783,000420,000-296,000-4,486,0002,511,0001,386,0003,987,0006,478,0005,194,0003,662,000
CFO
1m
-86.21%
3,402,0001,816,0002,487,0001,160,000-386,0003,518,0002,637,0001,574,000-494,0001,550,0001,646,0007,791,000-3,260,000-6,892,0009,028,000-12,9996,446,0003,882,0009,677,0001,334,000
Dividend
May 29, 20251.9 GBP/sh

Profile

Avingtrans plc manufactures and sells engineered components, systems, and services to the energy, medical, and infrastructure industries worldwide. It operates in three segments: Energy-EPM, Energy-PSRE, and Medical-MII. The company designs, manufactures, integrates, and services electric motors and pumps, steam turbines, gas compressors, pressure vessels, blast doors, containers, and skidded systems. It also designs and manufactures equipment for the medical, science and research communities, including products for medical diagnostic equipment; high performance pressure, vacuum vessels, and composite materials for research organizations; and superconducting magnets and helium-free cryogenic systems for use in magnetic resonance imaging and nuclear magnetic resonance. The company was incorporated in 1985 and is based in Chatteris, the United Kingdom.
IPO date
Dec 08, 2000
Employees
704
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑052016‑05
Income
Revenues
136,615
17.33%
116,437
17.52%
Cost of revenue
130,979
110,350
Unusual Expense (Income)
NOPBT
5,636
6,087
NOPBT Margin
4.13%
5.23%
Operating Taxes
1,180
1,246
Tax Rate
20.94%
20.47%
NOPAT
4,456
4,841
Net income
3,662
-29.50%
5,194
-19.82%
Dividends
(1,441)
(1,331)
Dividend yield
1.12%
0.98%
Proceeds from repurchase of equity
563
589
BB yield
-0.44%
-0.44%
Debt
Debt current
8,031
4,580
Long-term debt
25,981
3,997
Deferred revenue
368
Other long-term liabilities
328
3,328
Net debt
21,897
(18,690)
Cash flow
Cash from operating activities
1,334
9,677
CAPEX
(3,967)
(8,692)
Cash from investing activities
(13,577)
(12,633)
Cash from financing activities
6,780
(3,400)
FCF
(11,396)
5,429
Balance
Cash
12,115
17,717
Long term investments
9,550
Excess cash
5,284
21,445
Stockholders' equity
98,244
96,711
Invested Capital
132,015
94,652
ROIC
3.93%
5.17%
ROCE
3.91%
5.10%
EV
Common stock shares outstanding
33,361
33,007
Price
3.85
-6.10%
4.10
-8.89%
Market cap
128,440
-5.09%
135,330
-9.24%
EV
152,907
119,053
EBITDA
12,176
11,243
EV/EBITDA
12.56
10.59
Interest
1,175
570
Interest/NOPBT
20.85%
9.36%